Insitro is the operator of a data-driven drug discovery and development company that uses machine learning and high-throughput biology to transform the way drugs are discovered and delivered to patients. The company uses state-of-the-art technologies from bioengineering, enabling it to generate high-throughput and functional genomic datasets and align them with patient data via novel machine learning methods, thereby building predictive models that can accelerate target selection and the design and development of effective therapeutics.
Generative AI is, by its very nature, a game-changer. It’s not about automation; it's about amplification. It augments our abilities, pushing the boundaries of what's possible, transformi...
Generative AI is advancing exponentially. What is happening at the frontier of research and application and how are novel techniques and approaches changing the risks and opportunities li...
Where do you see yourself and your team a year from now? What impacts will small decisions now have in 5 to 10 years? In this special compilation episode of Meet The Leader, heads of top ...